MedTrace Logo

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

NCT01739673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2018-09-26

No results posted yet for this study

Summary

This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.

Conditions

  • Infectious Keratitis

Interventions

OTHER

Ultraviolet-A and riboflavin

Sponsors & Collaborators

  • Cxlusa

    lead INDUSTRY

Principal Investigators

  • William Trattler, MD · Center For Excellence In Eye Care

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01739673 on ClinicalTrials.gov